TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...

Get access to Brad Slager's "Riffed From the Headlines," a daily VIP feature where he looks to bring accountability to the ...